Advertisement

Loading...

Galenica AG

GALNFPNK
Healthcare
Medical - Distribution
$116.19
$0.00(0.00%)
U.S. Market opens in 11h 54m

Galenica AG Fundamental Analysis

Galenica AG (GALNF) shows moderate financial fundamentals with a PE ratio of 25.40, profit margin of 4.37%, and ROE of 12.38%. The company generates $4.1B in annual revenue with moderate year-over-year growth of 4.67%.

Key Strengths

PEG Ratio-5.36

Areas of Concern

Operating Margin9.06%
Cash Position2.00%
We analyze GALNF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.1/100

We analyze GALNF's fundamental strength across five key dimensions:

Efficiency Score

Weak

GALNF struggles to generate sufficient returns from assets.

ROA > 10%
5.41%

Valuation Score

Moderate

GALNF shows balanced valuation metrics.

PE < 25
25.40
PEG Ratio < 2
-5.36

Growth Score

Weak

GALNF faces weak or negative growth trends.

Revenue Growth > 5%
4.67%
EPS Growth > 10%
-35.84%

Financial Health Score

Excellent

GALNF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.72
Current Ratio > 1
1.15

Profitability Score

Weak

GALNF struggles to sustain strong margins.

ROE > 15%
12.38%
Net Margin ≥ 15%
4.37%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is GALNF Expensive or Cheap?

P/E Ratio

GALNF trades at 25.40 times earnings. This indicates a fair valuation.

25.40

PEG Ratio

When adjusting for growth, GALNF's PEG of -5.36 indicates potential undervaluation.

-5.36

Price to Book

The market values Galenica AG at 3.10 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.10

EV/EBITDA

Enterprise value stands at 11.55 times EBITDA. This signals the market has high growth expectations.

11.55

How Well Does GALNF Make Money?

Net Profit Margin

For every $100 in sales, Galenica AG keeps $4.37 as profit after all expenses.

4.37%

Operating Margin

Core operations generate 9.06 in profit for every $100 in revenue, before interest and taxes.

9.06%

ROE

Management delivers $12.38 in profit for every $100 of shareholder equity.

12.38%

ROA

Galenica AG generates $5.41 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.41%

Following the Money - Real Cash Generation

Operating Cash Flow

Galenica AG generates limited operating cash flow of $299.86M, signaling weaker underlying cash strength.

$299.86M

Free Cash Flow

Galenica AG produces free cash flow of $272.44M, offering steady but limited capital for shareholder returns and expansion.

$272.44M

FCF Per Share

Each share generates $5.47 in free cash annually.

$5.47

FCF Yield

GALNF converts 5.92% of its market value into free cash.

5.92%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

25.40

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-5.36

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.10

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.72

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.12

vs 25 benchmark

ROA

Return on assets percentage

0.05

vs 25 benchmark

ROCE

Return on capital employed

0.16

vs 25 benchmark

How GALNF Stacks Against Its Sector Peers

MetricGALNF ValueSector AveragePerformance
P/E Ratio25.4028.31 Better (Cheaper)
ROE12.38%699.00% Weak
Net Margin4.37%-130884.00% (disorted) Weak
Debt/Equity0.720.34 Weak (High Leverage)
Current Ratio1.152775.16 Neutral
ROA5.41%-14469.00% (disorted) Weak

GALNF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Galenica AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

17.23%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

44.69%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

4.48%

Industry Style: Defensive, Growth, Innovation

Growing

Fundamental Analysis FAQ